Christopher Chapman
Pharmacist · Boise, ID
Christopher Chapman is a pharmacist with a practice address in Boise, Idaho, and NPI 1316514508, issued on Jun 7, 2021. Check the license (Idaho P9274, as entered in NPPES) with the Idaho board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Christopher Chapman
- Primary taxonomy
- Pharmacist 183500000X
- License number
- P9274 ID
Self-reported in NPPES; status is on the state search - Practice location
- 1515 W State St, Boise, ID 83702
- Phone
- (208) 345-7684
- Enumerated
- Jun 7, 2021
- Entity
- Type 1 · individual
Also registered at 1515 W State St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Matthew ArakiPharmacist1760093124
- Jacob Crossley, PHARMDPharmacist1588205959
- Cori Farrar, PHARMDPharmacist1669607776
- Annie GoyerPharmacy Technician1366142408
- Justin Hammond, PHARMDPharmacist1538634381
- Anthony Hollis, PHARMDPharmacist1013326156
Verify Christopher Chapman in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Idaho board licenses this profession
Search for license P9274Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
50% more Medicare Part D claims than the average pharmacist in 2024
190 Medicare Part D claims for 156 beneficiaries, against an average of 127 among the 28,933 providers of this specialty who prescribed in Part D. Brand-name drugs were 98% of claims.
Most prescribed
- Abrysvo106 claims
- Shingrix59 claims
- Adacel Tdap22 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
480 pharmacist records list a Boise practice address
They are 480 of the 9,467 NPPES records with a Boise practice address, and 1,776 pharmacist records in Idaho.
All 480 in Boise → All 1,776 in Idaho → Every provider in Boise →
Other pharmacist records in Idaho
- Brooke Ackerman, PHARMDRathdrum, ID1962285957
- Peter Adamovich, PHARMDPocatello, ID1568078046
- Jennifer Adams, PHARM.D., ED.D.Meridian, ID1356481691
- Jordan Adams, PHARMDIdaho Falls, ID1083741243
- Spencer Adams, PHARM DPocatello, ID1033483292
- Sheryl AdamsonBoise, ID1710173901
- Samuel Adjei, PHARMDMeridian, ID1275468365
- Shah Afshar, RPHEagle, ID1902277536
- Dora Aguayo, PHARMDBoise, ID1245965987
- Danielle AhlstromBoise, ID1659714459
Common questions
What is Christopher Chapman's NPI number?
Christopher Chapman's National Provider Identifier (NPI) is 1316514508, issued on Jun 7, 2021. An NPI identifies a provider in billing; it is not a license.
Where is Christopher Chapman located?
The NPPES record lists a practice address at 1515 W State St, Boise, ID, 83702. Phone: (208) 345-7684. Providers update this record themselves, so call before visiting.
How can I verify Christopher Chapman's license?
NPPES lists Idaho license number P9274, as entered by the provider. Search the Idaho board that licenses this profession; the NPPES record confirms identity only.
How much does Christopher Chapman prescribe under Medicare Part D?
In 2024, Christopher Chapman had 190 Medicare Part D claims for 156 beneficiaries; the average among pharmacist prescribers was 127. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.